Healthcare -
Biotechnology - NASDAQ - US
$ 572.78
-0.117 %
$ 61.6 B
Market Cap
14.93
P/E
REGN - ACCOUNTS PAYABLE
Accounts Payable REGN - Regeneron Pharmaceuticals, Inc.
790 M
LAST VALUE
15.76%
2 YEAR CAGR
13.56%
5 YEAR CAGR
23.01%
10 YEAR CAGR